Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open?

Lohr, Frank; Georg, Dietmar; Cozzi, Luca; Eich, Hans Theodor; Weber, Damien Charles; Koeck, Julia; Knäusl, Barbara; Dieckmann, Karin; Abo-Madyan, Yasser; Fiandra, Christian; Mueller, Rolf-Peter; Engert, Andreas; Ricardi, Umberto (2014). Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open? Strahlentherapie und Onkologie, 190(10), pp. 864-871. Springer-Medizin-Verlag 10.1007/s00066-014-0719-9

[img] Text
art%3A10.1007%2Fs00066-014-0719-9.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (874kB) | Request a copy

PURPOSE Hodgkin lymphoma (HL) is a highly curable disease. Reducing late complications and second malignancies has become increasingly important. Radiotherapy target paradigms are currently changing and radiotherapy techniques are evolving rapidly. DESIGN This overview reports to what extent target volume reduction in involved-node (IN) and advanced radiotherapy techniques, such as intensity-modulated radiotherapy (IMRT) and proton therapy-compared with involved-field (IF) and 3D radiotherapy (3D-RT)- can reduce high doses to organs at risk (OAR) and examines the issues that still remain open. RESULTS Although no comparison of all available techniques on identical patient datasets exists, clear patterns emerge. Advanced dose-calculation algorithms (e.g., convolution-superposition/Monte Carlo) should be used in mediastinal HL. INRT consistently reduces treated volumes when compared with IFRT with the exact amount depending on the INRT definition. The number of patients that might significantly benefit from highly conformal techniques such as IMRT over 3D-RT regarding high-dose exposure to organs at risk (OAR) is smaller with INRT. The impact of larger volumes treated with low doses in advanced techniques is unclear. The type of IMRT used (static/rotational) is of minor importance. All advanced photon techniques result in similar potential benefits and disadvantages, therefore only the degree-of-modulation should be chosen based on individual treatment goals. Treatment in deep inspiration breath hold is being evaluated. Protons theoretically provide both excellent high-dose conformality and reduced integral dose. CONCLUSION Further reduction of treated volumes most effectively reduces OAR dose, most likely without disadvantages if the excellent control rates achieved currently are maintained. For both IFRT and INRT, the benefits of advanced radiotherapy techniques depend on the individual patient/target geometry. Their use should therefore be decided case by case with comparative treatment planning.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Weber, Damien Charles

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0179-7158

Publisher:

Springer-Medizin-Verlag

Language:

English

Submitter:

Beatrice Scheidegger

Date Deposited:

10 Mar 2015 15:19

Last Modified:

09 Nov 2015 10:03

Publisher DOI:

10.1007/s00066-014-0719-9

PubMed ID:

25209551

BORIS DOI:

10.7892/boris.61600

URI:

https://boris.unibe.ch/id/eprint/61600

Actions (login required)

Edit item Edit item
Provide Feedback